Signal Transduction and Targeted Therapy
Academic journal
- Biomedicine
- Pharmacology
- Carlo M. Croce
- Kang Zhang
- Yu-Quan Wei
Nature Research
Open access
Impact factor
ISO 4 (alt) · Bluebook (alt1 · alt2)
NLM (alt) · MathSciNet (alt
![Paid subscription required](http://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png)
CODEN (alt · alt2) · JSTOR (alt) · LCCN (alt)
MIAR · NLM (alt) · Scopus
2059-3635 (web)
- Journal homepage
- Online archive
Signal Transduction and Targeted Therapy is a multidisciplinary peer-reviewed open access scientific journal covering biomedical research with a particular focus on signal transduction and its application to the drug development process. It was established in 2016 and is published by Nature Research. The editors-in-chief are Carlo M. Croce (Ohio State University), Kang Zhang (Macau University of Science and Technology), and Yu-Quan Wei (West China Medical Center). According to the Journal Citation Reports, the journal has a 2022 impact factor of 39.3.[1]
References
- ^ "Signal Transduction and Targeted Therapy". 2020 Journal Citation Reports. Web of Science (Science ed.). Clarivate Analytics. 2021.
- v
- t
- e